Our future depends on it.
We strive to get it right every time.
Software company Take2 Technologies and the Chinese University of Hong Kong filed a patent infringement lawsuit against Pacific Biosciences of California on Wednesday in Delaware District Court.
Dec 15, 2022 | law.comBoston Children's Hospital is partnering with PacBio to use its HiFi sequencing technology to identify rare pediatric diseases.
Dec 7, 2022 | beckershospitalreview.comWhipsaw partnered with PacBio to identify an all-new user interaction model and to design a stunning new industrial design for the instrument, including an intuitive user interface.
Nov 30, 2022 | core77.comRecently, Pacb announced Revio, Onso, and MAS-Seq, three new products to provide the most accurate long-read, short-read, and single-cell RNA sequencing data possible.
Nov 21, 2022 | pacb.comPacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the Revio™ long-read sequencing system, which will enable customers to dramatically scale their use of PacBio’s celebrated HiFi sequencing technology.
Oct 24, 2022 | pacb.comPacBio, this month, announced the creation of the Consortium for Long Read Sequencing, which aims to accelerate the utility of long-read human genome datasets.
Oct 24, 2022 | nasdaq.comPacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the launch of its Multiplexed Arrays Sequencing (MAS-Seq) kit in partnership with the Broad Institute of MIT and Harvard and 10x Genomics, Inc.
Oct 19, 2022 | imoscancer.orgSequencing company PacBio, and synthetic DNA company Twist Bioscience announced today the launch of a line of high-throughput long-read gene panels.
Oct 19, 2022 | insideprecisionmedicine.comPacBio and Twist collaborated with researchers at leading institutions to develop two Alliance panels.
Oct 18, 2022 | pacb.comThis May, PacBio announced a team up with iLAC and the Robotic Biology Institute to develop end-to-end automated workflows for its sequencing platforms, the Robotic Biology Institute is looking for ways to integrate its LabDroid humanoid robot into sequencing flows to achieve 24/7 uninterrupted high throughput capabilities.
May 8, 2022 | prnasia.comPacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, welcomes Michael Eberle, Ph.D., as Vice President of Computational Biology.
Jan 1, 2022 | pacb.com“Since Pacb launched the Sequel II based clinical program in China, Pacb has seen great interest and excitement from the medical community.
Jan 1, 2022 | pacb.comPacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, announced today a new collaboration with global agriculture company, Corteva Agriscience, to develop custom, end-to-end workflows for plant, pest and microbial sequencing.
Jan 1, 2022 | pacb.comToday, Pacb is excited to share the latest milestone in this pursuit with the launch of SMRT Link v11.0.
Jan 1, 2022 | pacb.comPacBio also introduced a new single-reaction sequencing plate and SMRT Cell 8M tray that better enables customers to run samples at their convenience.
Jan 1, 2022 | pacb.com"Jeff is joining PacBio at a critical time as we continue in our efforts to expand our sequencing portfolio to become a multiplatform solution provider, scale our global commercial footprint and move towards profitability.
Jan 1, 2022 | prnewswire.comCanada Pension Plan Investment Board has invested 0.01% in Pacific Biosciences of California, Inc. (NASDAQ:PACB).
Jan 1, 2019 | makdaily.com